The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
The facility will manufacture its Herceptin biosimilar, Tuznue
The brand has added a range of exciting new products especially formulated for oily skin.
Adds five years of market exclusivity on approval
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines
The global multi-center phase-II clinical trial will be a 36-week, multi-center, randomized, double-blind, placebo-controlled trial, followed by a 36-week open-label extension period
Subscribe To Our Newsletter & Stay Updated
